- Asthma Slideshow Pictures
- Take the Asthma Quiz!
- Asthma Myths and Facts
- Patient Comments: Churg-Strauss Syndrome - Symptoms
- Patient Comments: Churg-Strauss Syndrome - Treatments
- Find a local Pulmonologist in your town
How is Churg-Strauss syndrome treated?
The treatment of patients with Churg-Strauss syndrome is directed toward both immediately quieting the inflammation of the blood vessels (vasculitis) and suppressing the immune system. Treatment usually includes high doses of cortisone-related medication (such as prednisone or prednisolone) to calm the inflammation and suppression of the active immune system with cyclophosphamide (Cytoxan).
Traditionally, cyclophosphamide has been given for a year or more in patients with Churg-Strauss syndrome. In a research study, Churg-Strauss syndrome patients did equally well if treated with cyclophosphamide for 6 or for 12 months. This study suggests that doctors might now be able to recommend a shorter (and, therefore, less toxic) course of Cytoxan for patients with Churg-Strauss syndrome.
What is the outlook (prognosis) for patients with Churg-Strauss syndrome?
Churg-Strauss syndrome is a serious disease that can be fatal. Untreated it is extremely dangerous and threatens the organs that are affected. With aggressive treatment and monitoring it can be quieted and total inactivation of the disease (remission) is possible.
Medically reviewed by Robert J. Bryg, MD; Board Certified Internal Medicine with subspecialty in Cardiovascular Disease
King, Talmadge E., MD. "Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)," UptoDate. Updated Jul 8, 2016.